Stock News

Morgan Stanley Reiterates $135 Target Price On Cimarex Energy (XEC), Reiterates Overweight Rating; Select Equity Group LP Lifted Idexx Labs (IDXX) Position

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Logo

Select Equity Group Lp increased Idexx Labs Inc (IDXX) stake by 18.99% reported in 2017Q4 SEC filing. Select Equity Group Lp acquired 56,436 shares as Idexx Labs Inc (IDXX)’s stock rose 21.09%. The Select Equity Group Lp holds 353,596 shares with $55.30 billion value, up from 297,160 last quarter. Idexx Labs Inc now has $17.73 billion valuation. The stock increased 2.09% or $4.17 during the last trading session, reaching $204.16. About 422,628 shares traded. IDEXX Laboratories, Inc. (NASDAQ:IDXX) has risen 23.99% since May 24, 2017 and is uptrending. It has outperformed by 12.44% the S&P500.

Morgan Stanley currently has a $135 price target on the $9.13 billion market cap company or 41.15% upside potential. In a note revealed on 24 May, Cimarex Energy (NYSE:XEC) stock had its Overweight Rating reaffirmed by analysts at Morgan Stanley.

More recent IDEXX Laboratories, Inc. (NASDAQ:IDXX) news were published by: Seekingalpha.com which released: “IDEXX: This Medical Equipment Stock Is Overvalued And Could Go Down As Much As 20%” on May 19, 2018. Also Nasdaq.com published the news titled: “IDEXX Laboratories Barks Out Another Successful Quarter” on May 11, 2018. Seekingalpha.com‘s news article titled: “Buy Diamondback Energy On Declines – Cramer’s Lightning Round (5/11/18)” with publication date: May 14, 2018 was also an interesting one.

Since January 9, 2018, it had 2 insider buys, and 7 insider sales for $23.44 million activity. On Monday, February 5 AYERS JONATHAN W sold $6.45 million worth of IDEXX Laboratories, Inc. (NASDAQ:IDXX) or 36,000 shares. 9,470 IDEXX Laboratories, Inc. (NASDAQ:IDXX) shares with value of $1.97M were sold by END WILLIAM T. 1,000 shares valued at $178,045 were bought by Kingsley Lawrence D on Wednesday, February 14. Another trade for 6,602 shares valued at $1.20 million was sold by MCKEON BRIAN P. 1,000 shares were bought by Claflin Bruce L., worth $179,580 on Wednesday, February 7. JUNIUS DANIEL M sold 2,974 shares worth $565,232.

Investors sentiment decreased to 0.81 in Q4 2017. Its down 0.05, from 0.86 in 2017Q3. It dropped, as 30 investors sold IDXX shares while 217 reduced holdings. 64 funds opened positions while 137 raised stakes. 72.13 million shares or 17.89% less from 87.85 million shares in 2017Q3 were reported. Stephens Inv Mgmt Gru Incorporated Ltd Co holds 0.98% or 275,133 shares. The Georgia-based Invesco Limited has invested 0.05% in IDEXX Laboratories, Inc. (NASDAQ:IDXX). Riverhead Management Limited Liability Corporation has invested 0.02% in IDEXX Laboratories, Inc. (NASDAQ:IDXX). Cobblestone Cap Advsrs Limited Liability Corporation New York has 51,763 shares. Moreover, City has 0% invested in IDEXX Laboratories, Inc. (NASDAQ:IDXX). United Capital Advisers Lc invested in 0.03% or 21,957 shares. Lombard Odier Asset Mgmt (Switzerland) holds 45,000 shares. 3,702 are owned by Veritable Ltd Partnership. Shelton Cap Mngmt has invested 0.07% in IDEXX Laboratories, Inc. (NASDAQ:IDXX). Martingale Asset Management LP accumulated 3,004 shares. Eulav Asset owns 230,500 shares. Ls Invest Advsr Llc reported 4,084 shares. Art Limited Liability, a New York-based fund reported 13,300 shares. Glob X Ltd Liability Company reported 0.01% in IDEXX Laboratories, Inc. (NASDAQ:IDXX). Oppenheimer Asset reported 6,732 shares.

Among 11 analysts covering IDEXX Laboratories (NASDAQ:IDXX), 7 have Buy rating, 2 Sell and 2 Hold. Therefore 64% are positive. IDEXX Laboratories had 29 analyst reports since July 24, 2015 according to SRatingsIntel. C.L. King upgraded the stock to “Buy” rating in Friday, July 28 report. Credit Suisse initiated the shares of IDXX in report on Thursday, February 4 with “Outperform” rating. The firm has “Buy” rating by Stifel Nicolaus given on Thursday, February 1. Stifel Nicolaus maintained the shares of IDXX in report on Thursday, October 29 with “Buy” rating. The stock has “Buy” rating by Stifel Nicolaus on Thursday, August 13. The company was maintained on Tuesday, June 13 by Canaccord Genuity. The stock of IDEXX Laboratories, Inc. (NASDAQ:IDXX) has “Neutral” rating given on Friday, April 1 by CL King. Stifel Nicolaus maintained the shares of IDXX in report on Monday, October 23 with “Buy” rating. Bank of America reinitiated the shares of IDXX in report on Thursday, September 29 with “Neutral” rating. Credit Suisse maintained IDEXX Laboratories, Inc. (NASDAQ:IDXX) on Wednesday, April 13 with “Outperform” rating.

Select Equity Group Lp decreased Bio Techne Corp (NASDAQ:TECH) stake by 370,154 shares to 1.34 million valued at $173.57 billion in 2017Q4. It also reduced Cantel Medical Corp (NYSE:CMN) stake by 19,347 shares and now owns 125,062 shares. West Pharmaceutical Svsc Inc (NYSE:WST) was reduced too.

The stock decreased 3.73% or $3.71 during the last trading session, reaching $95.64. About 1.64 million shares traded or 24.11% up from the average. Cimarex Energy Co. (NYSE:XEC) has declined 20.15% since May 24, 2017 and is downtrending. It has underperformed by 31.70% the S&P500.

Since December 12, 2017, it had 0 buys, and 8 sales for $3.41 million activity. $250,763 worth of Cimarex Energy Co. (NYSE:XEC) was sold by Johnson Krista L. 3,000 shares valued at $337,769 were sold by Barron Francis Brian on Tuesday, December 12. JORDEN THOMAS E sold 2,500 shares worth $250,000. Shares for $185,853 were sold by LOGAN HAROLD R JR on Wednesday, February 28. 2,000 shares valued at $224,822 were sold by ALBI JOSEPH R on Friday, December 15. Another trade for 13,000 shares valued at $1.48 million was sold by Lambuth John.

Another recent and important Cimarex Energy Co. (NYSE:XEC) news was published by Gurufocus.com which published an article titled: “World Capital Markets in Red Wednesday” on May 23, 2018.

Investors sentiment increased to 1.21 in Q4 2017. Its up 0.06, from 1.15 in 2017Q3. It improved, as 29 investors sold Cimarex Energy Co. shares while 139 reduced holdings. 64 funds opened positions while 140 raised stakes. 85.60 million shares or 1.05% less from 86.51 million shares in 2017Q3 were reported. Fmr Ltd Llc holds 0.06% or 4.42 million shares in its portfolio. Millennium Mgmt invested in 0.04% or 266,249 shares. Atlantic Trust Gp Ltd Liability stated it has 0.06% in Cimarex Energy Co. (NYSE:XEC). Pub Employees Retirement Association Of Colorado has invested 0.11% in Cimarex Energy Co. (NYSE:XEC). North Star Invest Mngmt owns 606 shares or 0.01% of their US portfolio. Meeder Asset invested in 0.08% or 7,842 shares. Texas Permanent School Fund, Texas-based fund reported 26,007 shares. Moreover, Mitchell Grp has 5.4% invested in Cimarex Energy Co. (NYSE:XEC) for 259,100 shares. Suntrust Banks Inc has invested 0% of its portfolio in Cimarex Energy Co. (NYSE:XEC). Balyasny Asset Management Ltd Com has 0.01% invested in Cimarex Energy Co. (NYSE:XEC). 48,661 were accumulated by Beddow Cap Mgmt. Icon Advisers Co stated it has 1.7% in Cimarex Energy Co. (NYSE:XEC). Glenmede Trust Communications Na holds 0% of its portfolio in Cimarex Energy Co. (NYSE:XEC) for 165 shares. Raymond James And Assoc stated it has 0.04% in Cimarex Energy Co. (NYSE:XEC). Eagle Boston Inv Management Inc owns 1,953 shares or 0.02% of their US portfolio.

Cimarex Energy Co. operates as an independent gas and oil exploration and production firm primarily in Oklahoma, Texas, and New Mexico. The company has market cap of $9.13 billion. As of December 31, 2016, it had a total proved gas and oil reserves of 2.89 trillion cubic feet equivalent consisting of 1.47 trillion cubic feet of natural gas, 0.64 Tcfe of oil, and 0.78 Tcfe of natural gas liquids primarily located in the Mid-Continent and Permian Basin regions. It has a 18.41 P/E ratio. The firm also owned interests in 3,094 net productive gas and oil wells.

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *